Cargando…

OR05-1 Genetic Discovery and Translational Decision Support from Exome Sequencing of 45,231 Type 2 Diabetes Cases and Controls from Five Ancestries

Analysis of human exome sequences, the protein-coding regions of genomes, has the potential to identify variation in genes relevant to disease for expedited clinical and therapeutic translation. Here we present results from a massive-scale type 2 diabetes (T2D) exome sequencing project. We analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Udler, Miriam, Flannick, Jason, Mercader, Josep, Fuchsberger, Christian, Mahajan, Anubha, Consortium, for the AMP-T2D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554762/ http://dx.doi.org/10.1210/js.2019-OR05-1

Ejemplares similares

MON-186 An Evaluation of the Ability of Current Exome Sequence Datasets to Retrospectively Validate Drugs for T2D or Related Metabolic Traits
por: Gupta, Adit, et al.
Publicado: (2019)

OR26-05 The Correction Factor for A1C in Anemic Patients
por: Villacreses, Maria Chang, et al.
Publicado: (2020)

OR05-4 Androgen Induced Metabolic Dysfunction in Female Mice is Prevented by Deletion of Liver Androgen Receptor
por: Wu, Sheng, et al.
Publicado: (2019)

OR08-05 Sex and Ethnic Differences in Advanced Lipoprotein Profiles in South Asians, African-Americans, and Caucasians
por: Sarcone, Camila, et al.
Publicado: (2020)

OR05-2 Targeted Inhibition of Glutamate Dehydrogenase by Alpha-Tocopherol: A Potential Novel Treatment for Hyperinsulinism Hyperammonemia Syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2019)

OR05-6 The Effect of the GLP1R Variant rs6923761 on Post-Prandial Glucose Levels during Treatment with Sitagliptin
por: Mashayekhi, Mona, et al.
Publicado: (2019)

OR14-05 Hepatocyte Peroxisome Proliferator-Activated Receptor Gamma (PPARG) Offsets the Anti-Steatogenic Effects of Thiazolidinediones in Obese Male Mice
por: Muratalla, Jose T, et al.
Publicado: (2020)

OR05-3 Mir-21 Contributes to Cytokine-Induced Beta Cell Dysfunction via Inhibition of mRNAs Regulating Beta Cell Identity
por: Ibrahim, Sara, et al.
Publicado: (2019)

OR05-5 AZP-3404, a 9-Amino Acid Peptide Analog of Insulin-Like Growth Factor-Binding Protein 2, Reverses Insulin Resistance in Leptin-Deficient ob/ob Mice
por: Milano, Stephane, et al.
Publicado: (2019)

An Open-Access Platform for Translating Diabetes and Cardiometabolic Disease Genetics Into Accessible Knowledge
por: Costanzo, Maria, et al.
Publicado: (2021)

OR26-08 Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11)
por: Frias, Juan Pablo, et al.
Publicado: (2020)

PSUN231 Adoptive Cell Transfer for Type 1 Diabetes Reversal
por: Imam, Shahnawaz, et al.
Publicado: (2022)

MON-LB024 Episodic Hypoglycemia in Non-Diabetics: Differentiating Distressing from Deadly
por: Windham, Mary, et al.
Publicado: (2019)

MON-LB028 Comparing Cardiovascular Effects of GLP-1 Agonists in a Real World Setting
por: Wallia, Amisha, et al.
Publicado: (2019)

MON-158 Association between Famine Exposure in Early Life with Insulin Resistance and β-cell Dysfunction in Adulthood
por: Wang, Yuying, et al.
Publicado: (2019)

MON-159 Increased Gluconeogenesis and Lower Glycogenolysis in Patients with Non-Selective Compared Selective Insulin Resistance
por: Sekizkardes, Hilal, et al.
Publicado: (2019)

MON-164 The Non-insulin-based METS-IR Index Combined With Liver Transaminases Improves Prediction Of Fatty Liver And Fibrosis
por: Bello-Chavolla, Omar, et al.
Publicado: (2019)

MON-162 Hepatic DNA Damage Induced by ENDS Is Associated with Decreased Levels of NAD+
por: Espinoza-Derout, Jorge, et al.
Publicado: (2019)

MON-150 Phone Call Reminders and Mobile Health Apps: Do They Help Our Diabetic Patients?
por: Lu, Kevin, et al.
Publicado: (2019)

MON-182 Adaptable Amperometric Biosensor Platforms for the Diagnosis of Endocrine Disorders
por: Labban, Najwa, et al.
Publicado: (2019)

MON-129 An Unusual LMNA Mutation Causing a Complex Phenotype: When the Genetic Diagnosis Uncovers Novel Features
por: Andrade, Natália, et al.
Publicado: (2019)

MON-178 Vitamin D Treatment of Patients with Type 1 Diabetes Reduces RORy, FoxP3 and CD4 Gene Expression in T Helper Cells
por: Penna-Martinez, Marissa, et al.
Publicado: (2019)

MON-154 Abnormal Glucose Homeostasis in Spinal Muscular Atrophy (SMA) Leading to a Transient Episode of Diabetic Ketoacidosis (DKA)
por: Hossain, Sabina, et al.
Publicado: (2019)

MON-149 The Impact of Diabetes Educational Videos in Diabetes Attitudes in a Brazilian Population
por: Zappala, Renata, et al.
Publicado: (2019)

MON-177 The Effect of Gluten Protein Components on Type 1 Diabetes and the Viability of Treatment with Antioxidants
por: Goodman, Miri
Publicado: (2019)

MON-151 Hypertriglyceridemia and Acute Pancreatitis Leading to Ketoacidosis in a Patient with Type 2 Diabetes
por: Fishel, Heather, et al.
Publicado: (2019)

MON-189 Glycemic Control and the Presence of Complications in Glycogen Storage Disease Type I: Results from the Swiss Registry
por: Kaiser, Nathalie, et al.
Publicado: (2019)

MON-171 Diabetics' Perceptions about Insulin Are Major Barriers to Its Early Initiation: A Cross-Sectional Study
por: Arshad, Iqra, et al.
Publicado: (2019)

MON-124 Antibody-Mediated Extreme Insulin Resistance: The Importance of Pre-Treatment Screening
por: Mosaferi, Tina, et al.
Publicado: (2019)

MON-140 A Case of Gestational Starvation Ketoacidosis in a Diabetic Mother Mimicking the Presentation of Acute Coronary Syndrome
por: Ibrahim, Dina, et al.
Publicado: (2019)

MON-188 Characterization and Categorization Based on Genotype-Biochemical Phenotype Association in Fructose-1,6-Bisphosphatase Deficiency
por: Sakuma, Ikki, et al.
Publicado: (2019)

MON-170 Low Plasma Glucose Results from Primary Care Are Not Associated with Morbidity, Mortality, or Underlying Hypoglycemic Disorders
por: Linton, Kathryn, et al.
Publicado: (2019)

MON-LB029 The Influence of SGLT-2 Inhibitors and Other Glucose-Lowering Therapies on All-Cause Mortality Risk and Cardiovascular Outcomes in Older Patients with Newly Treated Type 2 Diabetes: A Population-Based Cohort Study
por: Doyle, Mary-Anne, et al.
Publicado: (2019)

MON-183 Comparison of Continuous Glucose Monitor versus Meal Tolerance Test for Detection of Post-Bariatric Surgery Hypoglycemia
por: Lee, Clare, et al.
Publicado: (2019)

MON-176 Making Informed Decisions on the Selection of Antibodies Using dkNET (NIDDK Information Network)
por: Lin, Ko-Wei, et al.
Publicado: (2019)

MON-163 Lowering of Circulating FGF21 by Modulation of Bile Acid Metabolism in Healthy Males
por: Al-Khaifi, Amani, et al.
Publicado: (2019)

MON-144 Free Diabetes Mhealth Apps and a Patient Survey: Is Medication Adherence a Concern?
por: Wu, Gloria, et al.
Publicado: (2019)

MON-190 Endo ECHO Improves Patient-Reported Measures of Access to Care, Health Care Quality, Self-Care Behaviors, and Overall Quality of Life for Patients with Complex Diabetes in Medically Underserved Areas of New Mexico
por: Paul, Margaret, et al.
Publicado: (2019)

MON-130 Optimal Glycemic Control in a Patient with HNF1A MODY with GLP1-RA Monotherapy: Implications for Future Therapy
por: Fantasia, Kathryn, et al.
Publicado: (2019)

SAT-132 Improvements Seen Among Clinicians Post-CME Related to Second-Line T2D Therapy
por: Larkin, Amy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k71moif98la7u2mc644p7f229p